{"title":"SIRT1/NOX1 pathway mediated ameliorative effects of rosmarinic acid in folic acid-induced renal injury.","authors":"Maryam Mottaghi, Akram Eidi, Fatemeh Heidari, Tahereh Komeili Movahhed, Azam Moslehi","doi":"10.4103/RPS.RPS_213_23","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and purpose: </strong>Renal injury is a serious disorder that can be caused by some diseases or agents. Rosmarinic acid (RA) is a natural and safe compound with powerful antioxidant and anti-inflammatory properties. In this study, the ameliorative effects of RA were assayed in folic acid (FA)-induced renal injury by involving the SIRT1/NOX1 pathway.</p><p><strong>Experimental approach: </strong>Thirty-six male C57/BL6 mice were divided into 6 groups (n = 6) including control, vehicle, FA, RA, FA + RA 50, and FA + RA 100. After 10 days, blood urea nitrogen (BUN), creatinine, and oxidative stress were measured. The expression of SIRT1 and NOX1 proteins was evaluated by western blot. Also, histopathological alterations were assayed by H&E and PAS staining methods.</p><p><strong>Findings/results: </strong>BUN and creatinine were significantly higher in the FA group compared to the control group; however, their levels decreased after RA treatment in both doses. A significant decrease was observed in swelling, necrosis, and desquamation of tubular epithelial cells in the FA + RA 50 and FA + RA 100 groups compared to the FA group. RA in the animals receiving FA increased SIRT1 expression and the levels of GSH and SOD compared to the FA group. RA in the animals receiving FA showed a significant decrease in NOX1 expression and MDA level compared to the FA group.</p><p><strong>Conclusion and implications: </strong>The findings declared that the administration of RA has positive effects against renal damage induced by FA. The effect might result from involvement in the SIRT1/NOX1 pathway and thereby attenuation of oxidative stress.</p>","PeriodicalId":21075,"journal":{"name":"Research in Pharmaceutical Sciences","volume":"19 5","pages":"622-633"},"PeriodicalIF":2.1000,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11648342/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research in Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/RPS.RPS_213_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background and purpose: Renal injury is a serious disorder that can be caused by some diseases or agents. Rosmarinic acid (RA) is a natural and safe compound with powerful antioxidant and anti-inflammatory properties. In this study, the ameliorative effects of RA were assayed in folic acid (FA)-induced renal injury by involving the SIRT1/NOX1 pathway.
Experimental approach: Thirty-six male C57/BL6 mice were divided into 6 groups (n = 6) including control, vehicle, FA, RA, FA + RA 50, and FA + RA 100. After 10 days, blood urea nitrogen (BUN), creatinine, and oxidative stress were measured. The expression of SIRT1 and NOX1 proteins was evaluated by western blot. Also, histopathological alterations were assayed by H&E and PAS staining methods.
Findings/results: BUN and creatinine were significantly higher in the FA group compared to the control group; however, their levels decreased after RA treatment in both doses. A significant decrease was observed in swelling, necrosis, and desquamation of tubular epithelial cells in the FA + RA 50 and FA + RA 100 groups compared to the FA group. RA in the animals receiving FA increased SIRT1 expression and the levels of GSH and SOD compared to the FA group. RA in the animals receiving FA showed a significant decrease in NOX1 expression and MDA level compared to the FA group.
Conclusion and implications: The findings declared that the administration of RA has positive effects against renal damage induced by FA. The effect might result from involvement in the SIRT1/NOX1 pathway and thereby attenuation of oxidative stress.
背景和目的:肾损伤是一种严重的疾病,可由某些疾病或药物引起。迷迭香酸(RA)是一种天然安全的化合物,具有强大的抗氧化和抗炎特性。本研究通过SIRT1/NOX1通路检测了RA对叶酸(FA)诱导的肾损伤的改善作用:将36只雄性C57/BL6小鼠分为6组(n = 6),包括对照组、车辆组、FA组、RA组、FA + RA 50组和FA + RA 100组。10 天后,测量血尿素氮(BUN)、肌酐和氧化应激。用 Western 印迹法评估了 SIRT1 和 NOX1 蛋白的表达。此外,还采用 H&E 和 PAS 染色法检测了组织病理学改变:研究结果/结果:与对照组相比,FA 组的尿素氮和肌酐明显升高,但两种剂量的 RA 治疗后,尿素氮和肌酐水平均有所下降。与 FA 组相比,FA + RA 50 组和 FA + RA 100 组肾小管上皮细胞的肿胀、坏死和脱屑明显减少。与 FA 组相比,接受 FA 的动物体内的 RA 增加了 SIRT1 的表达以及 GSH 和 SOD 的水平。与 FA 组相比,RA 组动物的 NOX1 表达和 MDA 水平显著降低:研究结果表明,服用 RA 对 FA 引起的肾损伤有积极作用。结论:研究结果表明,服用 RA 对 FA 引起的肾损伤有积极作用,其原因可能是参与了 SIRT1/NOX1 通路,从而减轻了氧化应激。
期刊介绍:
Research in Pharmaceutical Sciences (RPS) is included in Thomson Reuters ESCI Web of Science (searchable at WoS master journal list), indexed with PubMed and PubMed Central and abstracted in the Elsevier Bibliographic Databases. Databases include Scopus, EMBASE, EMCare, EMBiology and Elsevier BIOBASE. It is also indexed in several specialized databases including Scientific Information Database (SID), Google Scholar, Iran Medex, Magiran, Index Copernicus (IC) and Islamic World Science Citation Center (ISC).